Understanding Genetic Lysosomal Storage Disorders
Part of Brain & nervous system, Genetic & congenital, Hormones & metabolism clinical trials.
This study aims to understand genetic factors in lysosomal storage disorders—rare conditions where the body cannot break down certain substances. Researchers will collect information from patients with these disorders, their family members, and healthy volunteers to learn how these diseases develop and affect people over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a documented lysosomal storage disorder, are a carrier of one, or are a blood relative of someone diagnosed with one
- If you are a healthy volunteer or have Parkinson's disease without a lysosomal storage disorder, you must be at least 18 years old
- You are willing to participate in evaluations and allow researchers to collect information about your health
- If you have cognitive impairment, a legal guardian or authorized representative can consent on your behalf
- You are able and willing to comply with study procedures, or your doctor believes participation is safe for you
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial follows people with genetic neurodegenerative (brain-wasting) disorders over time to better understand how the condition changes. The goal is to learn patterns that could help future treatments or care plans.
This study looks at how standard treatments for Gaucher disease affect lung problems, bone damage, and parkinson-like symptoms. It aims to find better ways to treat these complications and improve quality of life.
This research study uses advanced MRI brain imaging to understand how a specific gene mutation (LRRK2) affects certain brain chemicals in people with Parkinson's disease. The goal is to learn more about how this genetic form of Parkinson's works, which could help develop better treatments.
This study looks at how certain genes might affect thinking and behavior in people with Parkinson's disease. If you have Parkinson's, take Parkinson's medication, and have had genetic testing, you may be able to join.
This study follows people with certain inherited metabolic conditions (like GM1 or GM2 gangliosidosis, sialidosis, or galactosialidosis) to learn more about how these diseases progress over time. Participating may help researchers understand the conditions better, which could improve future care.
This study is looking at people with inherited (genetic) neurological conditions, as well as their family members, to better understand these diseases. Participants will receive a thorough evaluation, which may help with diagnosis and research.
Hear when a new Gaucher Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.